Compounds > hydroxyindoleacetic acid

hydroxyindoleacetic acid and telotristat

hydroxyindoleacetic acid has been researched along with telotristat in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banks, P; Bergsland, E; Fleming, D; Frazier, K; Freiman, J; Jackson, J; Kulke, MH; Kvols, L; Lapuerta, P; Law, L; O'Dorisio, T; Phan, A; Sands, A; Yao, JC; Zambrowicz, B1
Banks, P; Caplin, M; Fleming, D; Hörsch, D; Lapuerta, P; Pavel, M; Ramage, J; Sands, A; Seufferlein, T; Valle, J; Wiedenmann, B; Zambrowicz, B1

Trials

2 trial(s) available for hydroxyindoleacetic acid and telotristat

ArticleYear
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.
    Endocrine-related cancer, 2014, Volume: 21, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Diarrhea; Female; Gastrointestinal Agents; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Phenylalanine; Pyrimidines; Serotonin Antagonists; Treatment Outcome

2014
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:4

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Female; Flushing; Gastrointestinal Transit; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome

2015